rdf:type |
|
lifeskim:mentions |
umls-concept:C0006823,
umls-concept:C0009952,
umls-concept:C0019994,
umls-concept:C0184666,
umls-concept:C0449450,
umls-concept:C0547047,
umls-concept:C0549384,
umls-concept:C0562508,
umls-concept:C0684224,
umls-concept:C0726639,
umls-concept:C0982332
|
pubmed:issue |
5
|
pubmed:dateCreated |
2003-11-3
|
pubmed:abstractText |
Acellular pertussis vaccines were introduced with the promise of an improved safety profile compared with whole-cell vaccines. In 1997-1998, Canada adopted 1 combination acellular pertussis vaccine, having previously used 1 particular combination whole-cell pertussis vaccine. We hypothesized that the change would result in a decrease in hospitalization rates for seizures and reports of hypotonic-hyporesponsive episodes (HHEs) temporally related to pertussis vaccination.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1098-4275
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e348
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14595075-Adverse Drug Reaction Reporting Systems,
pubmed-meshheading:14595075-Canada,
pubmed-meshheading:14595075-Child,
pubmed-meshheading:14595075-Child, Preschool,
pubmed-meshheading:14595075-Comorbidity,
pubmed-meshheading:14595075-Diphtheria-Tetanus-Pertussis Vaccine,
pubmed-meshheading:14595075-Diphtheria-Tetanus-acellular Pertussis Vaccines,
pubmed-meshheading:14595075-Emergency Service, Hospital,
pubmed-meshheading:14595075-Female,
pubmed-meshheading:14595075-Haemophilus Vaccines,
pubmed-meshheading:14595075-Hospitalization,
pubmed-meshheading:14595075-Humans,
pubmed-meshheading:14595075-Incidence,
pubmed-meshheading:14595075-Infant,
pubmed-meshheading:14595075-Male,
pubmed-meshheading:14595075-Measles-Mumps-Rubella Vaccine,
pubmed-meshheading:14595075-Muscle Hypotonia,
pubmed-meshheading:14595075-Poliovirus Vaccine, Inactivated,
pubmed-meshheading:14595075-Safety,
pubmed-meshheading:14595075-Seizures, Febrile,
pubmed-meshheading:14595075-Vaccines, Acellular
|
pubmed:year |
2003
|
pubmed:articleTitle |
Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.
|
pubmed:affiliation |
Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada. lesaux@cheo.on.ca
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|